GO:0051997 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051997 describes the molecular function of OHCU decarboxylase, the enzyme that catalyzes the final step of the ureide pathway, converting 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate (OHCU) to S-allantoin and CO2.
• The reaction is a metal-independent decarboxylation that proceeds through a unique mechanism involving a conserved active-site architecture and substrate destabilization.
• OHCU decarboxylase is found in organisms ranging from bacteria to plants and animals, but the human enzyme has lost catalytic function due to structural changes.
• Deficiency in upstream ureide pathway enzymes, such as 5-hydroxyisourate hydrolase, causes hepatomegaly and hepatocellular carcinoma in mice, highlighting the pathway's role in liver homeostasis.
• Structural and mechanistic studies on Klebsiella pneumoniae OHCU decarboxylase have provided the foundation for understanding this enzyme family.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the physiological roles of OHCU decarboxylase and related ureide pathway genes.
Description
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) is a molecular function defined by the Gene Ontology term GO:0051997. This enzyme catalyzes the final step in the oxidative degradation of uric acid, converting 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate (OHCU) to S-allantoin and carbon dioxide. The reaction is part of the ureide pathway, which allows organisms to break down purines and is particularly important in plants, fungi, and bacteria. In humans, the ureide pathway is non-functional due to the loss of several enzymes, including OHCU decarboxylase, leading to the accumulation of uric acid. Understanding OHCU decarboxylase activity is therefore relevant to evolutionary biology, microbial metabolism, and purine-related disorders. The enzyme has been structurally and mechanistically characterized in Klebsiella pneumoniae and other organisms, revealing a unique metal-independent decarboxylation mechanism. This article provides a comprehensive overview of GO:0051997, its biological context, key genes, disease associations, and modern research methods including CRISPR-based models.
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity At A Glance
| GO ID | GO:0051997 |
|---|---|
| GO term | 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity |
| Ontology | molecular_function |
| Synonym | OHCU decarboxylase activity; 4-(carbamoylamino)-5-hydroxy-2-oxo-2,5-dihydro-1H-imidazole-5-carboxylate decarboxylase activity |
| Definition | Catalysis of the reaction: 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H imidazole-5-carboxylate + H+ = S-allantoin + CO2. |
| Major function | Final step of the ureide pathway, converting OHCU to S-allantoin and CO2 |
| Substrate | 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate (OHCU) |
| Products | S-allantoin and CO2 |
| Cofactors | None known; metal-independent mechanism |
| Pathway | Ureide pathway (uric acid degradation) |
What Is GO:0051997?
GO:0051997, 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity, is a molecular function defined as the catalysis of the reaction: 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate + H+ = S-allantoin + CO2. In simpler terms, it is the enzyme activity that removes a carboxyl group from OHCU to produce S-allantoin and carbon dioxide. This activity is also known as OHCU decarboxylase activity or 4-(carbamoylamino)-5-hydroxy-2-oxo-2,5-dihydro-1H-imidazole-5-carboxylate decarboxylase activity. The reaction is the final step in the ureide pathway, which degrades uric acid to allantoin in organisms that possess the complete pathway.
Why Is 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity Important in Cell Biology?
OHCU decarboxylase activity is critical for the complete degradation of uric acid in organisms that possess the ureide pathway. This pathway allows the conversion of uric acid to allantoin, which is more soluble and can be excreted efficiently. In bacteria such as Klebsiella pneumoniae, this activity is part of a metabolic route that enables the use of uric acid as a nitrogen source. In plants, the ureide pathway is involved in nitrogen fixation and assimilation, and OHCU decarboxylase is essential for allantoin production. In humans, the ureide pathway is non-functional because the gene encoding OHCU decarboxylase has accumulated mutations that abolish catalytic activity, contributing to the high levels of uric acid in human plasma. Thus, studying this enzyme provides insights into evolutionary loss of metabolic functions and the pathophysiology of hyperuricemia and related disorders.
• OHCU decarboxylase catalyzes the final step of the ureide pathway, enabling the conversion of uric acid to allantoin.
• The enzyme is found in bacteria, plants, and some animals, but is non-functional in humans due to evolutionary mutations.
• Deficiency of upstream ureide pathway enzymes causes hepatomegaly and hepatocellular carcinoma in mice, indicating the pathway's role in liver health.
• Structural studies have revealed a unique metal-independent decarboxylation mechanism, making it a model for enzyme evolution.
• The enzyme is a potential target for engineering uric acid degradation in humans or for modulating nitrogen metabolism in plants.
• Understanding OHCU decarboxylase activity can inform research on purine metabolism disorders such as gout and hyperuricemia.
• The enzyme's role in allantoin production links it to oxidative stress responses, as allantoin is a marker of free radical damage.
• CRISPR-based models can help dissect the physiological consequences of loss or gain of OHCU decarboxylase function in various organisms.
Molecular Mechanism of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity
Substrate Binding and Active Site Architecture
In simple terms: The enzyme grabs the OHCU molecule in a specific pocket to start the reaction.
OHCU decarboxylase binds its substrate, OHCU, in a highly conserved active site. Structural studies on Klebsiella pneumoniae OHCU decarboxylase revealed that the substrate is recognized through a network of hydrogen bonds and hydrophobic interactions. The active site contains a conserved aspartate residue that is critical for catalysis, as well as other residues that position the substrate for decarboxylation. The enzyme does not require metal ions for activity, distinguishing it from many other decarboxylases.
Catalytic Mechanism of Decarboxylation
In simple terms: The enzyme breaks a carbon-carbon bond to release carbon dioxide and form allantoin.
The decarboxylation reaction proceeds through a mechanism that involves protonation of the substrate and destabilization of the carboxylate group. The conserved aspartate residue acts as a general acid, donating a proton to the substrate to facilitate the cleavage of the carbon-carbon bond. This leads to the release of CO2 and the formation of S-allantoin. The reaction is stereospecific, yielding only the S-enantiomer of allantoin. The mechanism is distinct from metal-dependent decarboxylases and has been elucidated through a combination of X-ray crystallography, site-directed mutagenesis, and kinetic studies.
Structural Conservation and Evolutionary Decline
In simple terms: The enzyme's structure is similar across species, but in humans it has lost its function.
OHCU decarboxylase is structurally conserved across bacteria, plants, and animals, but the human enzyme has accumulated mutations that render it catalytically inactive. Comparative structural analysis has shown that the human protein retains the overall fold but lacks key catalytic residues, leading to a loss of decarboxylase activity. This evolutionary decline is part of the broader loss of the ureide pathway in humans, which results in the accumulation of uric acid. The structural basis for this functional decline has been investigated using crystallography and biochemical assays.
Role in the Ureide Pathway
In simple terms: This enzyme is the last step in a chain that turns uric acid into allantoin.
In the ureide pathway, uric acid is first oxidized to 5-hydroxyisourate (HIU) by urate oxidase. HIU is then hydrolyzed to OHCU by 5-hydroxyisourate hydrolase (HIUHase). Finally, OHCU decarboxylase converts OHCU to S-allantoin and CO2. This pathway is present in many organisms but is incomplete in humans, where urate oxidase and HIUHase are also non-functional. The pathway is important for nitrogen metabolism in plants and for purine degradation in bacteria.
Key Genes Involved in GO:0051997 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity
The following genes and proteins are involved in OHCU decarboxylase activity and the broader ureide pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OHCU decarboxylase (Klebsiella pneumoniae) | Catalyzes the final step of the ureide pathway | Model enzyme for structural and mechanistic studies |
| HIUHase (5-hydroxyisourate hydrolase) | Hydrolyzes HIU to OHCU upstream of OHCU decarboxylase | Deficiency causes hepatomegaly and hepatocellular carcinoma in mice |
| Urate oxidase (UOX) | Oxidizes uric acid to HIU | Lost in humans, leading to high uric acid levels |
| Allantoin racemase (Klebsiella pneumoniae) | Interconverts allantoin enantiomers | Studied for its role in allantoin metabolism |
| Transthyretin-like protein (Arabidopsis thaliana) | May function in ureide metabolism | Functional characterization in plants |
| HSP70 (whitefly) | Heat-shock protein involved in stress response | Adaptive evolution in whitefly-wild tomato interaction |
| Human OHCU decarboxylase pseudogene | Non-functional due to mutations | Evolutionary loss of ureide pathway |
| HIUase (bacterial) | Hydrolyzes HIU | Part of ureide pathway in bacteria |
| Allantoinase | Hydrolyzes allantoin to allantoate | Downstream of OHCU decarboxylase |
| Allantoicase | Degrades allantoate | Further downstream in purine degradation |
| Ureidoglycolate hydrolase | Produces glyoxylate and urea | Final steps of ureide pathway |
| Urate oxidase (plant) | Oxidizes uric acid in plants | Role in nitrogen metabolism |
| Xanthine dehydrogenase | Produces uric acid from xanthine | Upstream of ureide pathway |
| Purine nucleoside phosphorylase | Purine salvage and degradation | Indirect role in uric acid production |
| Adenosine deaminase | Purine metabolism | Indirect role in uric acid production |
| Guanine deaminase | Converts guanine to xanthine | Upstream of uric acid |
| 5'-Nucleotidase | Produces nucleosides for purine catabolism | Upstream of uric acid |
| IMP dehydrogenase | GMP synthesis | Indirect role in purine pool |
How Is 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity Regulated?
The regulation of OHCU decarboxylase activity is not well characterized at the transcriptional or post-translational level. In bacteria, the ureide pathway genes are often organized in operons and may be regulated by nitrogen availability. However, specific regulators of OHCU decarboxylase expression have not been extensively studied. In plants, the expression of ureide pathway genes is developmentally regulated and influenced by nitrogen fixation. In humans, the gene is a pseudogene and is not expressed as a functional enzyme. Further research is needed to elucidate regulatory mechanisms.
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIUHase | Hepatomegaly and hepatocellular carcinoma in mice | Knockout mouse model |
| Urate oxidase | Hyperuricemia and gout in humans | Urate oxidase knockout mice |
| OHCU decarboxylase (human) | Loss of function, hyperuricemia | Humanized mouse models or cell lines |
| Allantoin racemase | Allantoin metabolism | Bacterial knockout models |
| Transthyretin-like protein | Plant nitrogen metabolism | Arabidopsis knockout lines |
Hepatomegaly and Hepatocellular Carcinoma
Deficiency of 5-hydroxyisourate hydrolase (HIUHase), the enzyme upstream of OHCU decarboxylase in the ureide pathway, causes hepatomegaly and hepatocellular carcinoma in mice. This suggests that disruption of the ureide pathway can lead to liver pathology, possibly due to the accumulation of toxic intermediates such as HIU or OHCU. Although OHCU decarboxylase deficiency alone has not been directly linked to liver disease, the pathway as a whole is important for liver homeostasis.
Hyperuricemia and Gout
In humans, the ureide pathway is non-functional because the genes encoding urate oxidase, HIUHase, and OHCU decarboxylase are mutated or lost. This results in the accumulation of uric acid, which can lead to hyperuricemia and gout. The loss of OHCU decarboxylase activity is one of the evolutionary changes that contributed to higher uric acid levels in humans, which may have provided a survival advantage but also increased the risk of gout.
Evolutionary and Metabolic Implications
The functional decline of OHCU decarboxylase in humans is an example of evolutionary loss of a metabolic function. This loss is part of a broader pattern of gene loss in the ureide pathway, which may have been advantageous in ancestral environments but now contributes to disease susceptibility. Studying this enzyme provides insights into how metabolic pathways evolve and how their loss can impact human health.
From 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of OHCU decarboxylase? | Point mutations in catalytic residues (e.g., aspartate) in Klebsiella pneumoniae OHCU decarboxylase, followed by kinetic assays |
| What are the physiological consequences of OHCU decarboxylase loss? | Knockout of the gene in bacteria or plants, or human cell lines with the pseudogene |
| Can OHCU decarboxylase activity be restored in human cells? | Knock-in of a functional OHCU decarboxylase gene into human cells |
| How does OHCU decarboxylase interact with other ureide pathway enzymes? | Tagged knock-in (e.g., GFP) for co-immunoprecipitation and imaging |
| What is the effect of OHCU decarboxylase overexpression? | Overexpression in bacterial or plant models to study allantoin production |
| How does OHCU decarboxylase contribute to nitrogen metabolism? | Knockout in Arabidopsis thaliana and analysis of nitrogen assimilation |
How to Study the 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure of protein | Determining active site architecture |
| Site-directed mutagenesis | Effect of specific amino acid changes on activity | Identifying catalytic residues |
| Enzyme kinetics | Catalytic efficiency and substrate specificity | Characterizing wild-type and mutant enzymes |
| CRISPR-Cas9 knockout | Loss of gene function | Studying physiological roles in model organisms |
| CRISPR-Cas9 knock-in | Introduction of specific mutations or tags | Creating disease models or tagged proteins |
| Metabolomics | Levels of metabolites | Assessing pathway flux and intermediate accumulation |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| qRT-PCR | mRNA expression levels | Measuring transcriptional changes |
Structural Biology (X-ray Crystallography and Cryo-EM)
X-ray crystallography has been instrumental in determining the structure of OHCU decarboxylase from Klebsiella pneumoniae, revealing the active site and substrate binding mode. Cryo-electron microscopy can be used for larger complexes. These methods provide atomic-level insights into the catalytic mechanism and can guide mutagenesis studies.
Enzyme Kinetics and Mutagenesis
Kinetic assays using purified enzyme and substrate analogs, combined with site-directed mutagenesis, have been used to identify critical residues for catalysis. These methods measure catalytic efficiency (kcat/Km) and can reveal the role of specific amino acids in substrate binding and turnover.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 can be used to generate knockout, knock-in, or point mutations in the OHCU decarboxylase gene or related pathway genes in various organisms. This allows researchers to study the physiological consequences of loss or gain of function in vivo.
Metabolomics and Flux Analysis
Metabolomic profiling can measure the levels of OHCU, allantoin, and other ureide pathway intermediates in cells or tissues. This helps assess the impact of genetic modifications on pathway flux and can identify compensatory changes.
How CRISPR Can Be Used to Study GO:0051997 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity
Knockout
CRISPR-Cas9 knockout of OHCU decarboxylase or upstream pathway genes (e.g., HIUHase) can be used to study the consequences of pathway disruption. For example, knockout of HIUHase in mice causes hepatomegaly and hepatocellular carcinoma. Similar approaches in bacteria or plants can reveal the role of OHCU decarboxylase in nitrogen metabolism.
Point Mutation
Point mutations in the catalytic residues of OHCU decarboxylase (e.g., the conserved aspartate) can be introduced using CRISPR-Cas9 homology-directed repair to dissect the mechanism. These mutations can abolish activity and help confirm the role of specific residues in catalysis.
Knock-in
Knock-in of a functional OHCU decarboxylase gene into human cells or model organisms that lack it can be used to restore ureide pathway activity. This can help determine whether the loss of this enzyme contributes to hyperuricemia and whether restoring it can lower uric acid levels.
Overexpression
Overexpression of OHCU decarboxylase in bacteria or plants can increase allantoin production and may be used to engineer nitrogen metabolism. For example, overexpression in Arabidopsis thaliana could enhance nitrogen use efficiency.
How EDITGENE Supports 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity Research
Researchers studying 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in ureide pathway function, allantoin production, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity research.
Frequently Asked Questions About 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity
What is 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity?
It is the enzyme activity defined by GO:0051997 that catalyzes the conversion of OHCU to S-allantoin and CO2, the final step of the ureide pathway.
What genes are involved in 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity?
The primary gene encodes OHCU decarboxylase itself. In bacteria, it is often found in operons with other ureide pathway genes such as HIUHase and allantoinase.
What is the function of OHCU decarboxylase in uric acid degradation?
It catalyzes the final step of uric acid degradation, converting OHCU to allantoin, which is more soluble and can be excreted.
Is OHCU decarboxylase active in humans?
No, the human enzyme is non-functional due to evolutionary mutations, contributing to high uric acid levels.
What diseases are associated with OHCU decarboxylase deficiency?
Deficiency of upstream pathway enzymes causes hepatomegaly and hepatocellular carcinoma in mice. In humans, loss of the pathway is linked to hyperuricemia and gout.
How is OHCU decarboxylase activity measured?
It is typically measured using enzyme kinetics with purified enzyme and substrate, monitoring the release of CO2 or formation of allantoin.
What is the mechanism of OHCU decarboxylase?
It uses a metal-independent mechanism involving a conserved aspartate residue that protonates the substrate and facilitates decarboxylation.
Can CRISPR be used to study OHCU decarboxylase?
Yes, CRISPR-Cas9 can generate knockout, knock-in, and point mutations in the OHCU decarboxylase gene to study its function in various organisms.
What model organisms are used to study OHCU decarboxylase?
Klebsiella pneumoniae, Arabidopsis thaliana, and mouse models are commonly used.
What are the research methods for OHCU decarboxylase?
X-ray crystallography, site-directed mutagenesis, enzyme kinetics, CRISPR genome editing, and metabolomics are key methods.
Conclusion
GO:0051997, 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity, represents a critical enzymatic step in the ureide pathway, responsible for the final conversion of OHCU to S-allantoin and CO2. Structural and mechanistic studies have revealed a unique metal-independent decarboxylation mechanism, and evolutionary analysis has shown that the human enzyme is non-functional, contributing to hyperuricemia. The pathway is also important in plants and bacteria for nitrogen metabolism. CRISPR-based models offer powerful tools to further dissect the physiological roles of this enzyme and its associated pathways. Future research may uncover new regulatory mechanisms and therapeutic opportunities.
References
- 1. French JB et al.. 2010. Structural and mechanistic studies on Klebsiella pneumoniae 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase.. J Biol Chem 285(46):35446-54 PMID: 20826786
- 2. Cendron L et al.. 2007. The structure of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase provides insights into the mechanism of uric acid degradation.. J Biol Chem 282(25):18182-18189 PMID: 17428786
- 3. Kim K et al.. 2007. Structural and functional basis for (S)-allantoin formation in the ureide pathway.. J Biol Chem 282(32):23457-64 PMID: 17567580
- 4. French JB et al.. 2011. Characterization of the structure and function of Klebsiella pneumoniae allantoin racemase.. J Mol Biol 410(3):447-60 PMID: 21616082
- 5. Rodrigues JT et al.. 2026. Structural conservation, functional decline: The fate of human OHCU decarboxylase.. Biochimie 246:120-137 PMID: 41956358
- 6. Pessoa J et al.. 2010. Functional characterization of Arabidopsis thaliana transthyretin-like protein.. BMC Plant Biol 10:30 PMID: 20167108
- 7. Stevenson WS et al.. 2010. Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice.. Proc Natl Acad Sci U S A 107(38):16625-30 PMID: 20823251
- 8. Tian J et al.. 2022. Heat-shock protein 70-a hub gene-underwent adaptive evolution involved in whitefly-wild tomato interaction.. Pest Manag Sci 78(11):4471-4479 PMID: 35796079
